Xiaoping Wu

机构：Hong Kong Polytechnic University, Chinese University of Hong Kong, Guangdong Pharmaceutical University, First Affiliated Hospital of Jiangxi Medical College, Kaili University, University of Hong Kong · ORCID：0000-0002-6910-0718

发表论文 48 篇 · 总被引 922 次 · h-index 14

代表论文

• Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study (2022 · The Lancet Respiratory Medicine · 被引 215)
• Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis (2018 · American Journal of Respiratory and Critical Care Medicine · 被引 148)
• Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells (2021 · Advanced Science · 被引 98)
• Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis (2021 · JAMA · 被引 78)
• SIRT1 downregulated FGB expression to inhibit RCC tumorigenesis by destabilizing STAT3 (2019 · Experimental Cell Research · 被引 39)
• Serum proteomic profiling of rheumatoid arthritis–interstitial lung disease with a comparison to idiopathic pulmonary fibrosis (2022 · Thorax · 被引 26)